Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2019-01-30 | 2019-02-01 | 74022 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2020-10-28 | 2020-11-02 | 127367 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-01 | 2022-09-15 | 168418 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2023-06-29 | 2024-01-19 | 196946 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2017-12-14 | 2018-02-15 | 32813 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2018-05-31 | 2018-10-05 | 50956 |
APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-08-09 | 2018-10-16 | 57792 |
APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-10-11 | 2018-10-16 | 63793 |
APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-01-15 | 2020-04-07 | 72357 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-03-13 | 2019-05-06 | 78529 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-09-18 | 2019-11-25 | 94171 |
APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2019-11-20 | 2020-04-07 | 99311 |
APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2020-05-13 | 2020-07-06 | 114949 |
APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187241 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-23 | 2023-08-04 | 196315 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-29 | 2023-08-04 | 196952 |
APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2023-09-07 | 2023-10-15 | 203825 |
APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2023-09-28 | 2023-10-15 | 205495 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |